Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0149 USD | +4.20% |
|
+35.45% | -76.31% |
05-24 | Roche, LumiraDx Deal Probed by U.K. Competition Watchdog | DJ |
05-20 | U.K. Competition Watchdog Weighs Potential Impact of Roche-LumiraDx | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-76.31% | 5.13M | |
+7.04% | 218B | |
+9.93% | 189B | |
+26.10% | 151B | |
+31.83% | 113B | |
+0.19% | 64.02B | |
+12.43% | 52.6B | |
+1.85% | 49.85B | |
-5.98% | 37.89B | |
-1.19% | 34.92B |
- Stock Market
- Equities
- LMDXF Stock
- News LumiraDx Limited
- Ladenburg Thalmann Adjusts LumiraDx Price Target to $12 From $14, Maintains Buy Rating